Global Molecular Diagnostics in Point of Care Market Research Report 2025(Status and Outlook)
Description
Report Overview
Molecular diagnostics in point of care refer to the use of molecular biology techniques to analyze biological markers in a patient's sample at or near the site of patient care. This approach enables rapid and accurate diagnosis of various diseases, including infectious diseases, genetic disorders, and certain types of cancer. Molecular diagnostics in point of care can provide healthcare professionals with real-time information, allowing for timely decision-making regarding patient management and treatment strategies. By bringing advanced molecular testing capabilities closer to the patient, this technology has the potential to revolutionize healthcare delivery by improving diagnostic accuracy, reducing turnaround times, and enhancing patient outcomes.
The market for molecular diagnostics in point of care is experiencing significant growth driven by several key factors. One of the primary market drivers is the increasing demand for rapid and accurate diagnostic testing in various healthcare settings, including hospitals, clinics, and physician offices. The shift towards personalized medicine and precision healthcare is also fueling the adoption of molecular diagnostics in point of care, as these technologies enable tailored treatment strategies based on individual patient profiles. Additionally, advancements in technology, such as the development of miniaturized testing platforms and portable devices, are making molecular diagnostics more accessible and user-friendly for healthcare providers. Moreover, the growing prevalence of infectious diseases and the need for early detection and monitoring are further driving the market for molecular diagnostics in point of care.
In addition to these drivers, the market for molecular diagnostics in point of care is also influenced by factors such as increasing investments in research and development, expanding applications of molecular testing in different disease areas, and rising awareness about the benefits of early disease detection. As healthcare systems worldwide continue to prioritize value-based care and patient-centered approaches, the demand for rapid and accurate diagnostic solutions like molecular diagnostics in point of care is expected to rise. With ongoing technological innovations and collaborations between industry players and healthcare providers, the market for molecular diagnostics in point of care is poised for continued growth and evolution in the coming years.
This report provides a deep insight into the global Molecular Diagnostics in Point of Care market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Molecular Diagnostics in Point of Care Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Molecular Diagnostics in Point of Care market in any manner.
Global Molecular Diagnostics in Point of Care Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Abbott
Accelerate Diagnostics
Ador Diagnostics
Beckman Coulter
Becton
Dickinson and Company
Binx Health
Biocartis
bioMérieux
Bio-Rad Laboratories
Bosch Healthcare Solutions
Curetis
Eurofins Scientific
Genetic Signatures
Grifols
Hibergene Diagnostics
Lumos Diagnostics
Roche
Siemens
Thermo Fisher Scientific
Market Segmentation (by Type)
Polymerase Chain Reaction
In Situ Hybridization
Gene Chips
Next Generation Sequencing
Market Segmentation (by Application)
Hospitals and Clinics
Independent Clinical Laboratories
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Molecular Diagnostics in Point of Care Market
Overview of the regional outlook of the Molecular Diagnostics in Point of Care Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Molecular Diagnostics in Point of Care Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Molecular diagnostics in point of care refer to the use of molecular biology techniques to analyze biological markers in a patient's sample at or near the site of patient care. This approach enables rapid and accurate diagnosis of various diseases, including infectious diseases, genetic disorders, and certain types of cancer. Molecular diagnostics in point of care can provide healthcare professionals with real-time information, allowing for timely decision-making regarding patient management and treatment strategies. By bringing advanced molecular testing capabilities closer to the patient, this technology has the potential to revolutionize healthcare delivery by improving diagnostic accuracy, reducing turnaround times, and enhancing patient outcomes.
The market for molecular diagnostics in point of care is experiencing significant growth driven by several key factors. One of the primary market drivers is the increasing demand for rapid and accurate diagnostic testing in various healthcare settings, including hospitals, clinics, and physician offices. The shift towards personalized medicine and precision healthcare is also fueling the adoption of molecular diagnostics in point of care, as these technologies enable tailored treatment strategies based on individual patient profiles. Additionally, advancements in technology, such as the development of miniaturized testing platforms and portable devices, are making molecular diagnostics more accessible and user-friendly for healthcare providers. Moreover, the growing prevalence of infectious diseases and the need for early detection and monitoring are further driving the market for molecular diagnostics in point of care.
In addition to these drivers, the market for molecular diagnostics in point of care is also influenced by factors such as increasing investments in research and development, expanding applications of molecular testing in different disease areas, and rising awareness about the benefits of early disease detection. As healthcare systems worldwide continue to prioritize value-based care and patient-centered approaches, the demand for rapid and accurate diagnostic solutions like molecular diagnostics in point of care is expected to rise. With ongoing technological innovations and collaborations between industry players and healthcare providers, the market for molecular diagnostics in point of care is poised for continued growth and evolution in the coming years.
This report provides a deep insight into the global Molecular Diagnostics in Point of Care market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Molecular Diagnostics in Point of Care Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Molecular Diagnostics in Point of Care market in any manner.
Global Molecular Diagnostics in Point of Care Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Abbott
Accelerate Diagnostics
Ador Diagnostics
Beckman Coulter
Becton
Dickinson and Company
Binx Health
Biocartis
bioMérieux
Bio-Rad Laboratories
Bosch Healthcare Solutions
Curetis
Eurofins Scientific
Genetic Signatures
Grifols
Hibergene Diagnostics
Lumos Diagnostics
Roche
Siemens
Thermo Fisher Scientific
Market Segmentation (by Type)
Polymerase Chain Reaction
In Situ Hybridization
Gene Chips
Next Generation Sequencing
Market Segmentation (by Application)
Hospitals and Clinics
Independent Clinical Laboratories
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Molecular Diagnostics in Point of Care Market
Overview of the regional outlook of the Molecular Diagnostics in Point of Care Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Molecular Diagnostics in Point of Care Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Table of Contents
195 Pages
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Molecular Diagnostics in Point of Care
- 1.2 Key Market Segments
- 1.2.1 Molecular Diagnostics in Point of Care Segment by Type
- 1.2.2 Molecular Diagnostics in Point of Care Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Molecular Diagnostics in Point of Care Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Molecular Diagnostics in Point of Care Market Size (M USD) Estimates and Forecasts (2020-2033)
- 2.1.2 Global Molecular Diagnostics in Point of Care Sales Estimates and Forecasts (2020-2033)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 Molecular Diagnostics in Point of Care Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global Molecular Diagnostics in Point of Care Product Life Cycle
- 3.3 Global Molecular Diagnostics in Point of Care Sales by Manufacturers (2020-2025)
- 3.4 Global Molecular Diagnostics in Point of Care Revenue Market Share by Manufacturers (2020-2025)
- 3.5 Molecular Diagnostics in Point of Care Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.6 Global Molecular Diagnostics in Point of Care Average Price by Manufacturers (2020-2025)
- 3.7 Manufacturers Molecular Diagnostics in Point of Care Sales Sites, Area Served, Product Type
- 3.8 Molecular Diagnostics in Point of Care Market Competitive Situation and Trends
- 3.8.1 Molecular Diagnostics in Point of Care Market Concentration Rate
- 3.8.2 Global 5 and 10 Largest Molecular Diagnostics in Point of Care Players Market Share by Revenue
- 3.8.3 Mergers & Acquisitions, Expansion
- 4 Molecular Diagnostics in Point of Care Industry Chain Analysis
- 4.1 Molecular Diagnostics in Point of Care Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Molecular Diagnostics in Point of Care Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Market Restraints
- 5.5 Industry News
- 5.5.1 New Product Developments
- 5.5.2 Mergers & Acquisitions
- 5.5.3 Expansions
- 5.5.4 Collaboration/Supply Contracts
- 5.6 PEST Analysis
- 5.6.1 Industry Policies Analysis
- 5.6.2 Economic Environment Analysis
- 5.6.3 Social Environment Analysis
- 5.6.4 Technological Environment Analysis
- 5.7 Global Molecular Diagnostics in Point of Care Market Porter's Five Forces Analysis
- 5.7.1 Global Trade Frictions
- 5.7.2 Global Trade Frictions and Their Impacts to Molecular Diagnostics in Point of Care Market
- 5.8 ESG Ratings of Leading Companies
- 6 Molecular Diagnostics in Point of Care Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Molecular Diagnostics in Point of Care Sales Market Share by Type (2020-2025)
- 6.3 Global Molecular Diagnostics in Point of Care Market Size Market Share by Type (2020-2025)
- 6.4 Global Molecular Diagnostics in Point of Care Price by Type (2020-2025)
- 7 Molecular Diagnostics in Point of Care Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Molecular Diagnostics in Point of Care Market Sales by Application (2020-2025)
- 7.3 Global Molecular Diagnostics in Point of Care Market Size (M USD) by Application (2020-2025)
- 7.4 Global Molecular Diagnostics in Point of Care Sales Growth Rate by Application (2020-2025)
- 8 Molecular Diagnostics in Point of Care Market Sales by Region
- 8.1 Global Molecular Diagnostics in Point of Care Sales by Region
- 8.1.1 Global Molecular Diagnostics in Point of Care Sales by Region
- 8.1.2 Global Molecular Diagnostics in Point of Care Sales Market Share by Region
- 8.2 Global Molecular Diagnostics in Point of Care Market Size by Region
- 8.2.1 Global Molecular Diagnostics in Point of Care Market Size by Region
- 8.2.2 Global Molecular Diagnostics in Point of Care Market Size Market Share by Region
- 8.3 North America
- 8.3.1 North America Molecular Diagnostics in Point of Care Sales by Country
- 8.3.2 North America Molecular Diagnostics in Point of Care Market Size by Country
- 8.3.3 U.S. Market Overview
- 8.3.4 Canada Market Overview
- 8.3.5 Mexico Market Overview
- 8.4 Europe
- 8.4.1 Europe Molecular Diagnostics in Point of Care Sales by Country
- 8.4.2 Europe Molecular Diagnostics in Point of Care Market Size by Country
- 8.4.3 Germany Market Overview
- 8.4.4 France Market Overview
- 8.4.5 U.K. Market Overview
- 8.4.6 Italy Market Overview
- 8.4.7 Spain Market Overview
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Molecular Diagnostics in Point of Care Sales by Region
- 8.5.2 Asia Pacific Molecular Diagnostics in Point of Care Market Size by Region
- 8.5.3 China Market Overview
- 8.5.4 Japan Market Overview
- 8.5.5 South Korea Market Overview
- 8.5.6 India Market Overview
- 8.5.7 Southeast Asia Market Overview
- 8.6 South America
- 8.6.1 South America Molecular Diagnostics in Point of Care Sales by Country
- 8.6.2 South America Molecular Diagnostics in Point of Care Market Size by Country
- 8.6.3 Brazil Market Overview
- 8.6.4 Argentina Market Overview
- 8.6.5 Columbia Market Overview
- 8.7 Middle East and Africa
- 8.7.1 Middle East and Africa Molecular Diagnostics in Point of Care Sales by Region
- 8.7.2 Middle East and Africa Molecular Diagnostics in Point of Care Market Size by Region
- 8.7.3 Saudi Arabia Market Overview
- 8.7.4 UAE Market Overview
- 8.7.5 Egypt Market Overview
- 8.7.6 Nigeria Market Overview
- 8.7.7 South Africa Market Overview
- 9 Molecular Diagnostics in Point of Care Market Production by Region
- 9.1 Global Production of Molecular Diagnostics in Point of Care by Region(2020-2025)
- 9.2 Global Molecular Diagnostics in Point of Care Revenue Market Share by Region (2020-2025)
- 9.3 Global Molecular Diagnostics in Point of Care Production, Revenue, Price and Gross Margin (2020-2025)
- 9.4 North America Molecular Diagnostics in Point of Care Production
- 9.4.1 North America Molecular Diagnostics in Point of Care Production Growth Rate (2020-2025)
- 9.4.2 North America Molecular Diagnostics in Point of Care Production, Revenue, Price and Gross Margin (2020-2025)
- 9.5 Europe Molecular Diagnostics in Point of Care Production
- 9.5.1 Europe Molecular Diagnostics in Point of Care Production Growth Rate (2020-2025)
- 9.5.2 Europe Molecular Diagnostics in Point of Care Production, Revenue, Price and Gross Margin (2020-2025)
- 9.6 Japan Molecular Diagnostics in Point of Care Production (2020-2025)
- 9.6.1 Japan Molecular Diagnostics in Point of Care Production Growth Rate (2020-2025)
- 9.6.2 Japan Molecular Diagnostics in Point of Care Production, Revenue, Price and Gross Margin (2020-2025)
- 9.7 China Molecular Diagnostics in Point of Care Production (2020-2025)
- 9.7.1 China Molecular Diagnostics in Point of Care Production Growth Rate (2020-2025)
- 9.7.2 China Molecular Diagnostics in Point of Care Production, Revenue, Price and Gross Margin (2020-2025)
- 10 Key Companies Profile
- 10.1 Abbott
- 10.1.1 Abbott Basic Information
- 10.1.2 Abbott Molecular Diagnostics in Point of Care Product Overview
- 10.1.3 Abbott Molecular Diagnostics in Point of Care Product Market Performance
- 10.1.4 Abbott Business Overview
- 10.1.5 Abbott SWOT Analysis
- 10.1.6 Abbott Recent Developments
- 10.2 Accelerate Diagnostics
- 10.2.1 Accelerate Diagnostics Basic Information
- 10.2.2 Accelerate Diagnostics Molecular Diagnostics in Point of Care Product Overview
- 10.2.3 Accelerate Diagnostics Molecular Diagnostics in Point of Care Product Market Performance
- 10.2.4 Accelerate Diagnostics Business Overview
- 10.2.5 Accelerate Diagnostics SWOT Analysis
- 10.2.6 Accelerate Diagnostics Recent Developments
- 10.3 Ador Diagnostics
- 10.3.1 Ador Diagnostics Basic Information
- 10.3.2 Ador Diagnostics Molecular Diagnostics in Point of Care Product Overview
- 10.3.3 Ador Diagnostics Molecular Diagnostics in Point of Care Product Market Performance
- 10.3.4 Ador Diagnostics Business Overview
- 10.3.5 Ador Diagnostics SWOT Analysis
- 10.3.6 Ador Diagnostics Recent Developments
- 10.4 Beckman Coulter
- 10.4.1 Beckman Coulter Basic Information
- 10.4.2 Beckman Coulter Molecular Diagnostics in Point of Care Product Overview
- 10.4.3 Beckman Coulter Molecular Diagnostics in Point of Care Product Market Performance
- 10.4.4 Beckman Coulter Business Overview
- 10.4.5 Beckman Coulter Recent Developments
- 10.5 Becton
- 10.5.1 Becton Basic Information
- 10.5.2 Becton Molecular Diagnostics in Point of Care Product Overview
- 10.5.3 Becton Molecular Diagnostics in Point of Care Product Market Performance
- 10.5.4 Becton Business Overview
- 10.5.5 Becton Recent Developments
- 10.6 Dickinson and Company
- 10.6.1 Dickinson and Company Basic Information
- 10.6.2 Dickinson and Company Molecular Diagnostics in Point of Care Product Overview
- 10.6.3 Dickinson and Company Molecular Diagnostics in Point of Care Product Market Performance
- 10.6.4 Dickinson and Company Business Overview
- 10.6.5 Dickinson and Company Recent Developments
- 10.7 Binx Health
- 10.7.1 Binx Health Basic Information
- 10.7.2 Binx Health Molecular Diagnostics in Point of Care Product Overview
- 10.7.3 Binx Health Molecular Diagnostics in Point of Care Product Market Performance
- 10.7.4 Binx Health Business Overview
- 10.7.5 Binx Health Recent Developments
- 10.8 Biocartis
- 10.8.1 Biocartis Basic Information
- 10.8.2 Biocartis Molecular Diagnostics in Point of Care Product Overview
- 10.8.3 Biocartis Molecular Diagnostics in Point of Care Product Market Performance
- 10.8.4 Biocartis Business Overview
- 10.8.5 Biocartis Recent Developments
- 10.9 bioMérieux
- 10.9.1 bioMérieux Basic Information
- 10.9.2 bioMérieux Molecular Diagnostics in Point of Care Product Overview
- 10.9.3 bioMérieux Molecular Diagnostics in Point of Care Product Market Performance
- 10.9.4 bioMérieux Business Overview
- 10.9.5 bioMérieux Recent Developments
- 10.10 Bio-Rad Laboratories
- 10.10.1 Bio-Rad Laboratories Basic Information
- 10.10.2 Bio-Rad Laboratories Molecular Diagnostics in Point of Care Product Overview
- 10.10.3 Bio-Rad Laboratories Molecular Diagnostics in Point of Care Product Market Performance
- 10.10.4 Bio-Rad Laboratories Business Overview
- 10.10.5 Bio-Rad Laboratories Recent Developments
- 10.11 Bosch Healthcare Solutions
- 10.11.1 Bosch Healthcare Solutions Basic Information
- 10.11.2 Bosch Healthcare Solutions Molecular Diagnostics in Point of Care Product Overview
- 10.11.3 Bosch Healthcare Solutions Molecular Diagnostics in Point of Care Product Market Performance
- 10.11.4 Bosch Healthcare Solutions Business Overview
- 10.11.5 Bosch Healthcare Solutions Recent Developments
- 10.12 Curetis
- 10.12.1 Curetis Basic Information
- 10.12.2 Curetis Molecular Diagnostics in Point of Care Product Overview
- 10.12.3 Curetis Molecular Diagnostics in Point of Care Product Market Performance
- 10.12.4 Curetis Business Overview
- 10.12.5 Curetis Recent Developments
- 10.13 Eurofins Scientific
- 10.13.1 Eurofins Scientific Basic Information
- 10.13.2 Eurofins Scientific Molecular Diagnostics in Point of Care Product Overview
- 10.13.3 Eurofins Scientific Molecular Diagnostics in Point of Care Product Market Performance
- 10.13.4 Eurofins Scientific Business Overview
- 10.13.5 Eurofins Scientific Recent Developments
- 10.14 Genetic Signatures
- 10.14.1 Genetic Signatures Basic Information
- 10.14.2 Genetic Signatures Molecular Diagnostics in Point of Care Product Overview
- 10.14.3 Genetic Signatures Molecular Diagnostics in Point of Care Product Market Performance
- 10.14.4 Genetic Signatures Business Overview
- 10.14.5 Genetic Signatures Recent Developments
- 10.15 Grifols
- 10.15.1 Grifols Basic Information
- 10.15.2 Grifols Molecular Diagnostics in Point of Care Product Overview
- 10.15.3 Grifols Molecular Diagnostics in Point of Care Product Market Performance
- 10.15.4 Grifols Business Overview
- 10.15.5 Grifols Recent Developments
- 10.16 Hibergene Diagnostics
- 10.16.1 Hibergene Diagnostics Basic Information
- 10.16.2 Hibergene Diagnostics Molecular Diagnostics in Point of Care Product Overview
- 10.16.3 Hibergene Diagnostics Molecular Diagnostics in Point of Care Product Market Performance
- 10.16.4 Hibergene Diagnostics Business Overview
- 10.16.5 Hibergene Diagnostics Recent Developments
- 10.17 Lumos Diagnostics
- 10.17.1 Lumos Diagnostics Basic Information
- 10.17.2 Lumos Diagnostics Molecular Diagnostics in Point of Care Product Overview
- 10.17.3 Lumos Diagnostics Molecular Diagnostics in Point of Care Product Market Performance
- 10.17.4 Lumos Diagnostics Business Overview
- 10.17.5 Lumos Diagnostics Recent Developments
- 10.18 Roche
- 10.18.1 Roche Basic Information
- 10.18.2 Roche Molecular Diagnostics in Point of Care Product Overview
- 10.18.3 Roche Molecular Diagnostics in Point of Care Product Market Performance
- 10.18.4 Roche Business Overview
- 10.18.5 Roche Recent Developments
- 10.19 Siemens
- 10.19.1 Siemens Basic Information
- 10.19.2 Siemens Molecular Diagnostics in Point of Care Product Overview
- 10.19.3 Siemens Molecular Diagnostics in Point of Care Product Market Performance
- 10.19.4 Siemens Business Overview
- 10.19.5 Siemens Recent Developments
- 10.20 Thermo Fisher Scientific
- 10.20.1 Thermo Fisher Scientific Basic Information
- 10.20.2 Thermo Fisher Scientific Molecular Diagnostics in Point of Care Product Overview
- 10.20.3 Thermo Fisher Scientific Molecular Diagnostics in Point of Care Product Market Performance
- 10.20.4 Thermo Fisher Scientific Business Overview
- 10.20.5 Thermo Fisher Scientific Recent Developments
- 11 Molecular Diagnostics in Point of Care Market Forecast by Region
- 11.1 Global Molecular Diagnostics in Point of Care Market Size Forecast
- 11.2 Global Molecular Diagnostics in Point of Care Market Forecast by Region
- 11.2.1 North America Market Size Forecast by Country
- 11.2.2 Europe Molecular Diagnostics in Point of Care Market Size Forecast by Country
- 11.2.3 Asia Pacific Molecular Diagnostics in Point of Care Market Size Forecast by Region
- 11.2.4 South America Molecular Diagnostics in Point of Care Market Size Forecast by Country
- 11.2.5 Middle East and Africa Forecasted Sales of Molecular Diagnostics in Point of Care by Country
- 12 Forecast Market by Type and by Application (2026-2033)
- 12.1 Global Molecular Diagnostics in Point of Care Market Forecast by Type (2026-2033)
- 12.1.1 Global Forecasted Sales of Molecular Diagnostics in Point of Care by Type (2026-2033)
- 12.1.2 Global Molecular Diagnostics in Point of Care Market Size Forecast by Type (2026-2033)
- 12.1.3 Global Forecasted Price of Molecular Diagnostics in Point of Care by Type (2026-2033)
- 12.2 Global Molecular Diagnostics in Point of Care Market Forecast by Application (2026-2033)
- 12.2.1 Global Molecular Diagnostics in Point of Care Sales (K Units) Forecast by Application
- 12.2.2 Global Molecular Diagnostics in Point of Care Market Size (M USD) Forecast by Application (2026-2033)
- 13 Conclusion and Key Findings
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
